Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding.
Bor MV, Feddersen S, Pedersen IS, Sidelmann JJ, Kristensen SR.
Semin Thromb Hemost. 2022 Mar;48(2):161-173. doi: 10.1055/s-0041-1730358. Epub 2021 Jul 14.
Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
Li Y, Ding B, Wang X, Ding Q.
Thromb Res. 2022 Sep;217:36-47. doi: 10.1016/j.thromres.2022.07.005. Epub 2022 Jul 14.
Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature.
Yan J, Luo M, Xiang L, Wu Y, Lin F.
Clin Chim Acta. 2022 Mar 1;528:1-5. doi: 10.1016/j.cca.2022.01.009. Epub 2022 Jan 19.
Pseudohomozygous dysfibrinogenemia.
Peck RC, Fitzgibbon L, Reilly-Stitt C, Doherty C, Phillips E, Mumford AD.
Res Pract Thromb Haemost. 2021 Aug 21;5(6):e12568. doi: 10.1002/rth2.12568. eCollection 2021 Aug.
Dysfibrinogenemia and thrombosis.
Mosesson MW.
Semin Thromb Hemost. 1999;25(3):311-9. doi: 10.1055/s-2007-994933.
Congenital dysfibrinogenemia.
Martinez J.
Curr Opin Hematol. 1997 Sep;4(5):357-65. doi: 10.1097/00062752-199704050-00010.
Dysfibrinogenemia and thrombosis.
Hayes T.
Arch Pathol Lab Med. 2002 Nov;126(11):1387-90. doi: 10.5858/2002-126-1387-DAT.
Diagnosis and management of dysfibrinogenemia.
Shapiro SE.
Clin Adv Hematol Oncol. 2018 Sep;16(9):602-605.
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
Casini A, Neerman-Arbez M, Ariëns RA, de Moerloose P.
J Thromb Haemost. 2015 Jun;13(6):909-19. doi: 10.1111/jth.12916. Epub 2015 May 2.
Laboratory diagnosis of dysfibrinogenemia.
Cunningham MT, Brandt JT, Laposata M, Olson JD.
Arch Pathol Lab Med. 2002 Apr;126(4):499-505. doi: 10.5858/2002-126-0499-LDOD.
